ClinicalTrials.gg
Drug

Sofosbuvir clinical trials

Also written Sovaldi®, GS-7977, PSI-7977 and SOF.

studies test it
159
open now
2
in phase 3
53
first study started
2010

Counted the way a researcher would: Sofosbuvir with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.

This browser remembers your choice.

How each study uses Sofosbuvir is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Sofosbuvir studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
6 Dec 2013 · SOVALDI · NDA 204671 (FDA, Drugs@FDA)
European Union
16 Jan 2014 · Sovaldi · EMEA/H/C/002798 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Sofosbuvir
53
Sofosbuvir (SOF)
3
daclatasvir
3
Harvoni
3
Sofosbuvir 400 MG
2

Brand

Sovaldi®
49

Development codes

GS-7977
41
PSI-7977
33

Other names

SOF
25

In one entry with another drug

Given together, or one or the other

sofosbuvir/velpatasvir
9
SOF/VEL
8
GS-7977/GS-5816
7
sofosbuvir and daclatasvir
5
Sofosbuvir/Daclatasvir
4
Sofosbuvir and Ledipasvir
3
Velpatasvir/Sofosbuvir
2
sofosbuvir/ledipasvir
2

Studies by the year they started

159 studies that test it; most in 2015 (30)

Studies that test Sofosbuvir, by start year
YearStudies
20103
20116
201212
201311
201418
201530
201619
201716
20189
201911
202011
20213
20226
20233
20241

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
9
Phase 2
62
Phase 3
53
Phase 4
36
No phase
11

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 75 · Other 84

Gilead Sciences (42) · Humanity and Health Research Centre (6) · Bristol-Myers Squibb (6) · Tehran University of Medical Sciences (5) · Assiut University (4) · Genuine Research Center, Egypt (4) · ANRS, Emerging Infectious Diseases (3) · Tanta University (3)

Often tested with

Tested in the same studies.

Ribavirin (34) · Velpatasvir (30) · Daclatasvir (29) · Simeprevir (16) · Ledipasvir (16) · Ledipasvir, sofosbuvir drug combination (10) · Ritonavir (5) · Elbasvir-grazoprevir drug combination (3)

Studies

Open first, then newest update. How each study uses Sofosbuvir is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 159

See all 159 studies that test Sofosbuvir →

Given beside what is tested · 55 — Sofosbuvir is usual care or a partner of the new treatment

Showing 20 of 55.

As the comparator · 8 — what is tested is compared with Sofosbuvir

What changed recently

From the registry's own updates since Oct 19, 2026.

Codes

What other systems call Sofosbuvir · ClinicalTrials.gg INT006597

  • MeSH (NLM) D000069474SofosbuvirConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) WJ6CA3ZU8BSOFOSBUVIRConfirmed FDA, NLM, Wikidata
  • RxNorm 1484911Confirmed FDA, Wikidata
  • Wikidata Q2502747sofosbuvirConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C101263SofosbuvirOne source FDA
  • DrugBank DB08934One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.